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Peptidyl-transferase ribozymes: trans reactions, structural 
characterization and ribosomal RNA-like features 
Wang Zhang* and Thomas R Cech 
Background: One of the most significant questions in understanding the origin 
of life concerns the order of appearance of DNA, RNA and protein during early 
biological evolution. If an ‘RNA world’ was a precursor to extant life, RNA must 
be able not only to catalyze RNA replication but also to direct peptide synthesis. 
Iterative RNA selection previously identified catalytic RNAs (ribozymes) that form 
amide bonds between RNA and an amino acid or between two amino acids. 
Results: We characterized peptidyl-transferase reactions catalyzed by two 
different families of ribozymes that use substrates that mimic A site and P site 
tRNAs. The family II ribozyme secondary structure was modeled using chemical 
modification, enzymatic digestion and mutational analysis. Two regions 
resemble the peptidyl-transferase region of 23s ribosomal RNA in sequence 
and structural context; these regions are important for peptide-bond formation. 
A shortened form of this ribozyme was engineered to catalyze intermolecular 
(‘trans’) peptide-bond formation, with the two amino-acid substrates binding 
through an attached AMP or oligonucleotide moiety. 
Conclusions: An in vitro-selected ribozyme can catalyze the same type of 
peptide-bond formation as a ribosome; the ribozyme resembles the ribosome 
because a very specific RNA structure is required for substrate binding and 
catalysis, and both amino acids are attached to nucleotides. It is intriguing that, 
although there are many different possible peptidyl-transferase ribozymes, the 
sequence and secondary structure of one is strikingly similar to the ‘helical 
wheel’ portion of 23s rRNA implicated in ribosomal peptidyl-transferase activity 
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Introduction 
Naturally occurring ribozymes efficiently catalyze the 
sequence-specific cleavage or ligation of RNA or DNA sub- 
strates; these natural reactions are limited to phosphate 
ester substrates [l]. The first demonstration that RNA can 
catalyze a reaction at a carbon center rather than a phospho- 
rus center involved a modified T&&ymena ribozyme that 
catalyzed hydrolysis of an aminoacyl ester [Z]. In recent 
years, in aitro selection and in vitro evolution methods have 
provided powerful tools for isolating ribozymes that can 
catalyze a wide range of chemical and biochemical reac- 
tions [3-121. Aminoacyl-transfer reactions can be catalyzed 
by ribozymes to form 3’-terminal aminoacyl esters and 
5’-terminal esters or amide bonds [13-151. Peptidyl-trans- 
ferase reactions can also be catalyzed by ribozymes to form 
amide bonds between two amino acids [16]. 
From a chemical point of view, peptide-bond formation is 
the most important step in the biosynthesis of a protein. 
The reaction, which is accomplished in nature on the ribo- 
some, takes place via the transfer of a peptidyl residue from 
peptidyl-tRNA in the ribosomal P site to the amino group 
of aminoacyl-tRNA in the A site (Figure la). Despite 
decades of intensive studies, the nature and the basic 
mechanism of the peptidyl-transferase reaction within the 
ribosome are still largely unknown. The discovery of cat- 
alytic RNA in the early 1980s [17,18] revitalized the 
hypothesis that RNA played a central role in some early 
stage of the evolution of life [19.20]. The ‘RNA world’ 
hypothesis proposed that RNA catalyzed its own self-repli- 
cation, as well as other biochemical reactions [Zl-241. The 
next key step occurred with the advent of RNA-catalyzed 
peptide synthesis. Today, ribosomal RNAs are thought to 
play an important role in protein biosynthesis, with the 
RNA having both structural and catalytic capacities [Z-27]. 
We have demonstrated previously that peptide-bond for- 
mation can be catalyzed -106-fold by RNA molecules iso- 
lated using in vitro selection methods [16]. The selection 
strategy for the peptidyl-transferase ribozymes utilized a 
pool of 196-mer RNA molecules randomized at 142 posi- 
tions. The 5’ end of each RNA was linked by a disulfide 
bond to a phenylalanine residue containing a free amino 
group. The phenylalanine of 5’-Phe-SS-GMPS-RNA 
(where GMPS is guanosine-S’-monophosphorothioate) 
provided the nucleophilic amino group that can attack the 
carbonyl carbon of the methionine of AMP-Met-Bio to 
form a peptide bond (Figure lb). The disulfide linkage of 
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Peptide-bond formation catalyzed by 
ribosome and ribozyme. (a) The peptidyl- 
transferase reaction catalyzed by the 
ribosome involves two substrates binding at 
two sites: aminoacyl-tRNA at the A site and 
f-Met-tRNA (or peptidyl-tRNA) at the P site. 
(b) Peptide-bond formation catalyzed by the 
trans ribozyme (derived from the family Ii clone 
25 ribozyme as described in this paper) 
employs two substrates: AMP-Met-Bio (black) 
functions as peptidyl-tRNA and 5’-Phe-linker- 
RNA (red) functions as aminoacyl-tRNA (wavy 
lines denote linker regions). 
5’-Phe-SS-GMPS-RNA allowed the final dipeptide 
product to be cleaved from the RNA by reducing the 
disulfide bond with dithiothreitol (DTT) and to be char- 
acterized using high performance liquid chromatography 
(HPLC) mass spectroscopy. 
Two major sequence families of peptidyl-transferase 
ribozymes were isolated previously [16]. Here, we charac- 
terize representatives from both families. We also convert 
a member of family II (clone 25) into a trans-acting 
ribozyme that catalyzes peptide-bond formation in a 
manner even more analogous to the reaction performed by 
the ribosome (Figure 1). 
RCSllltS 
A peptidyl-transferase ribozyme has specificity for AMP 
The peptidyl transferase ribozymes were selected to 
utilize an AMP-Met-Bio substrate [16]. The amino acid 
methionine is esterified to the Z’(3’) oxygen of AMP, as it 
is in an aminoacylated tRNA, and the amino group of 
methionine is blocked by derivatization with a linker that 
includes biotin, allowing selection on streptavidin beads. 
How does the peptidyl transferase ribozyme recognize its 
AMP-Met-Bio substrate? To test the contribution of the 
AMP moiety to substrate binding, we measured the ability 
of AMP to inhibit the clone 25 ribozyme peptidyl-trans- 
ferase reaction. Figure 2a shows a typical inhibition plot of 
ribozyme 25 by AMP at a constant concentration (0.4 mM) 
of AMP-Met-Bio substrate. After measuring five apparent 
Ki values with appropriate concentrations of AMP-Met- 
Bio, a Ki of 188 PM for AMP was determined from the 
intercept at zero concentration of AMP-Met-Bio by a best- 
fit linear plot of apparent K, versus substrate concentra- 
tion. The Ki for AMP is equal to the K, (190 PM) for the 
AMP-Met-Bio substrate [16], which suggests that the 
AMP moiety of the substrate contributes most of the 
binding affinity of AMP-Met-Bio for family II ribozymes. 
We also studied peptidyl-transferase reactions catalyzed by 
the family II ribozyme using other nucleoside-5’- 
monophosphates as inhibitors. The time courses of pep- 
tidy1 transfer in the presence of these nucleotides are 
shown in Figure 2b and plotted in Figure 2c. Clearly GMP, 
CMP, IMP and UMP do not inhibit the peptidyl-trans- 
ferase reactions at 1 mM concentrations; adenosine shows 
intermediate inhibition; and AMP and 3’,5’-ADP are the 
most inhibitory. The adenosyl of the nucleotide moiety of 
the substrate therefore interacts specifically with the 
family II ribozyme, and the 5’-phosphate of the substrate 
appears to contribute to interactions with the ribozyme. 
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AMP binding by the clone 25 ribozyme. (a) AMP inhibition of peptide- (b) Autoradiogram of the gel-shift analysis of the time course of 
bond formation catalyzed by 8 pM clone 25 ribozyme with 0.4 mM peptide-bond formation in the presence of nucleotide inhibitors, The 
AMP-Met-Bio, 50 mM HEPES (pH 7.4) and 300 mM KCI in the time points were 0, 5, 10, 20, 30, 60, 120 and 240 min. The bottom 
presence of 100 mM MgCI, at 25°C. The best-fit apparent Ki value bands are the unreacted 5’-Phe-linker-ribozyme and the top bands are 
was obtained by fitting the data to the Morrison equation using the the streptavidin::biotinylcaproyl-Phe-linker-ribozyme complexes. The 
KaleidoGraph program. The relative observed reaction samples were run on 7.5 M urea/8% polyacrylamide gels with 1 xTBE 
rate = 1 -(([Rbzl + [In] + KFpp)-[([Rbz] + [In] + K,+‘pj2 - 4[Rbz][lnl11’*}/ buffer at 1000 V, 14°C. (c) The plots of the fraction of the product 
2[Rbzl with K+‘P = 574 uM. Measurement of KFpp at five substrate versus time in the presence of 1 mM inhibitor (data came from 
concentrations allowed determination of K, = 188 uM for AMP. Figure 2b). In, inhibitor; P, product; S, substrate. 
Metal-ion dependence and specificity 
The peptidyl-transferase reactions of the ribozymes 
require metal ions [16]. We wished to know how tightly 
the RNA binds the metal, whether it is specific for the 
metal ion used during selection (Mgz+) and whether dif- 
ferent peptidyl-transferase ribozymes have similar metal 
ion requirements. Figure 3 shows the plots of the 
observed catalytic rate constants with various Mg2+ con- 
centrations for clone 16 (family I) and clone 2.5 (family II) 
ribozymes. The minimum Mgz+ concentration required 
for significant catalysis by the clone 25 ribozyme was 
about 10 mM and maximal activity was observed at 
100 mM. In contrast, the clone 16 ribozyme retained full 
catalytic activity at 10 mM Mg’+, the lowest concentration 
tested. The difference in hlgj+ dependence between the 
two families is interesting because both families were 
selected under the same conditions (.50 mhl Mg2+). 
We next tested whether other metal ions could substitute 
for hIg*+ in the reaction. We found that Cal+ could replace 
the Mg?+, at the same concentration. for both ribozyme 
families, albeit giving lower activities (data not shown). 
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Figure 3 Table 1 
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The Mg*+ concentration dependence of the peptidyl-transferase 
reactions catalyzed by the clone 16 and clone 25 ribozymes. Log plot: 
of Mg*+ concentration versus the observed peptidyl-transferase 
reaction rates (kobS in min-l) are shown (clone 16 ribozyme, red; clone 
25 ribozyme, blue). The reaction conditions are same as described in 
Figure 2, except that 800 yM AMP-Met-Bio substrate was used. 
5 
The addition of Zn2+ or Cua+ did not increase the catalytic 
activity of the family II ribozyme in the presenc,e of 
20 mM Mg2+ and actually inhibited peptide-bond forma- 
tion. Inhibition by Cu2+ and 2%’ might be caused by dea- 
cylation of the AMP-Met-Bio substrate because Cu2+ and 
Zn2+ promote the cleavage of the aminoacyl-ester bonds of 
charged tRNAs [28]. 
Secondary structure of the clone 25 ribozyme 
The secondary structure of the clone 25 ribozyme was ini- 
tially predicted using the Mfold program [29] (Figure 4). 
The secondary structure model consists of eight stem 
helixes (Pl-P8) and a large internal AU-rich loop (L3/4). 
Enzymatic probing was used to test this model (Figure 4). 
Reaction with single-strand-specific RNases T2 and U2 
at A26-A31, C41-A44 and A75-A78 is consistent with the 
L3/4 internal loop and L4 and L.5 hairpin loops. The posi- 
tions of A19, A67, A99, A136, A175 and Al76 in proposed 
bulge and hairpin regions were strongly cleaved by single- 
strand-specific RNase U2. The positions of G79-G80, 
G115 and G176 in proposed hairpin and bulge regions 
also showed strong cleavage by single-strand-specific 
nuclease Sl and RNase Tl. Sites of cleavage by double- 
strand-specific RNase Vl located on both sides of the 
putative P2, P3, P5, P6 and P8 helixes provide further 
support that these regions are double stranded. With the 
exception of one region of P4 that was cleaved by single- 
strand-specific nucleases, the nuclease digestion results are 
Deletion analysis of the clone 25 ribozyme. 
Deletion Deletion positions Activity 
1 Wild type NA ++ 
2 Internal 118-152 + 
3 Internal 112-158 + 
4 5’ Terminal l-23 - 
5 5’ Terminal l-38 
6 3’ Terminal 174-l 93 +I- 
7 3’ Terminal 163-193 
8 5’+3’ Terminal l-23 and 174-l 93 - 
9 5’+3’ Terminal l-38 and 163-l 93 
NA, not applicable. ++, full activity; +, reduced activity; +I-, low 
activity; -, activity not detected. 
in good agreement with the secondary-structure model of 
the clone 25 ribozyme. 
Chemical-modification analysis is also consistent with the 
secondary-structure model of the family II ribozyme. 
Chemical modification was performed with dimethyl 
sulfate (DMS) and 1-cyclohexyl-3-(Z-morpholino-ethyl)- 
carbodiimide metho-p-toluene sulfonate (CMCT), and 
the RNA was then reverse transcribed with 5’-labeled 
primers resulting in chain termination at modified posi- 
tions (Figure 5). The strongly modified nucleotides listed 
in the margins of Figure 5 are all predicted to be in single- 
stranded regions. These results are consistent with the 
large internal loop, hairpin loops and bulges of the sec- 
ondary-structure model (green symbols in Figure 4). 
We attempted to find the binding sites for the ribozyme 
substrates by footprinting. There was no change in the 
chemical-modification pattern of the RNA in the presence 
of saturating amounts of either the AMP-Met-Bio sub- 
strate or the 5’-Phe-linker (Figure 5), however. A chemi- 
cal-modification footprint might not be a suitable 
approach for characterizing the substrate-binding sites of 
the clone 25 ribozyme because DMS and CMCT modili- 
cation can only provide information about the interactions 
between the substrate and the ribozyme at Watson-Crick 
base-pairing positions. 
Deletion analysis 
We tried to minimize the size of the family II ribozyme by 
external and internal deletions based on the secondary 
structure model. The terminal deletions were from 5’-end, 
3’-end, or both 5’- and 3’-ends, and internal deletions 
involved the P6 and P7 regions. The results of the dele- 
tion experiments are summarized in Table 1. Truncated 
ribozymes with internal deletions at All%U152 and 
GllZ-Cl58 retained peptidyl-transferase activity, but 
there was a marked decrease in the catalytic rate. This 
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Secondary-structure model of the clone 25 ribozyme and the results of (blue); the double-strand-specific probe is RNase VI (red). The 
the chemical and enzymatic probing. The color symbols superimposed underlined nucleotides are the primer-binding sites for reverse 
on the structure show positions modified by single-strand-specific transcription: Al 74-G193 is the binding site for primer 1 and 
CMCT or DMS (green) or cleaved by single-strand-specific nucleases G93-G112 is the binding site for primer 2. 
suggests that the P6 and P7 regions might not form the 
catalytic center, but could be jnvolved in tertiary interac- 
tions that stabilize the active rl‘bozyme structure. A more 
dramatic decrease in catalytic activity resulted from dele- 
tion of A174-G193, and the other terminal deletions abol- 
ished catalytic activity. The fixed sequences at the 5’- and 
3’-ends are therefore necessary for catalysis by the 
family II ribozyme and could partially comprise the active 
site of this class of ribozymes and/or form part of the sub- 
strate-binding sites. Further experiments are required to 
elucidate the precise functions of these sequences. 
Tram reactions 
If the catalytic entity of the RNA could be physically sep- 
arated from the two substrates, investigations of struc- 
ture-function relationships would be facilitated; these 
changes would also make the system more closely mimic 
the ribosome. We therefore engineered ‘-A-site’ substrates 
in order to convert the clone 25 ribozyme to a trimolecular 
rrans-reacting system (Figure 6). Three substrates were 
constructed: ZO-mer, tl-mer and 4-mer oligonucleotides 
each with phenylalanine linked to its .5’-end (Figure 6a). 
Correspondingly, the 193-nucleotide (nt) clone 25 
ribozyme was truncated at its S’-end (with two S’-guano- 
sine nucleotides added to facilitate transcription) to gener- 
ate three new ribozymes of lengths 175 nt, 187 nt, and 
191 nt to be paired with the ZO-mer, X-mer, and 4-mer 
substrates, respectively. The third component of the tri- 
molecular tmn.r reaction was the AMP-hlet-Bio substrate 
originally used for the cis reaction. ‘I’he trimolecular reac- 
tions contained 8 @I of the appropriate tran~ riboz);me, 
800 @I AMP-Rlet-Bio substrate and 2C)-200 phi S’-Phe- 
linker-R&A substrate in the presence of 100-300 mhl 
hlgl+ at 25°C:. Figure 6b shows the time course of 
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Chemical-modification probing of clone 25 
ribozyme structure. Autoradiograms of a 
sequencing gel of clone 25 RNA (193 nt) 
without the Phe linker. After chemical 
modification with DMS and CMCT, the RNA 
was reverse transcribed with primer 1, which 
is complementary to Al 74-G193 (left side of 
figure), and with primer 2, which is 
complementary to G93-G112 (right side of 
figure); products were analyzed using gel 
electrophoresis and the gels scanned with a 
Phosphorlmager. Sites of chain termination 
are visualized as bands preceding the 
modified residue by one nucleotide on 
polyacrylamide gel electrophoresis because 
modification at one of the Watson-Crick 
positions stops the progress of reverse 
transcriptase at the nucleotide preceding the 
modified position. Control lanes: clone 25 
RNA was treated the same as other samples 
but the modifying agent was absent; lanes 1 
and 4, clone 25 ribozyme; lanes 2 and 5, 
clone 25 RNA plus 1 mM 5’-Phe-linker; 
lanes 3 and 6, clone 25 ribozyme plus 6 mM 
AMP-Met-Bio. 
peptide-bond formation catalyzed by the 17.5nt tram 
ribozyme using 5’-Phe-ZO-mer RNA as the second sub- 
strate; Figure 6c shows the time course of the 187-nt tram 
ribozyme using 5’-Phe-8-mer RNA as the second sub- 
strate. The products are visualized directly as bands with 
retarded mobility; this assay differs from that used for the 
cis reaction, where streptavidin is added to retard the 
mobility of the RNA molecules that have undergone the 
reaction (Figure 2). DTT and streptavidin treatments 
were consistent with the identification of the top bands of 
the gels in Figure 6 as the 5’-Bio-Met-Phe-ZO-mer RNA 
and 5’-Bio-Met-Phe-8-mer RNA products (data not 
shown). The ribozymes can therefore carry out peptidyl 
transfer using two intermolecular substrates. 
Both the .5’-Phe-ZO-mer and 5’-Phe-8-mer substrates par; 
ticipated in peptidyl-transferase reactions in the presence 
of 100 mM Mg2+, but no detectable product was 
observed in the absence of Mg*+. In contrast, the 5’-Phe- 
4-mer RNA substrate did not undergo a tram reaction in 
the presence of the appropriate 191-nt tram ribozyme 
with or without Mgz+. The catalytic activity of the 
175mer tram ribozyme with the 5’-Phe ZO-mer substrate 
was similar to the activity of the wild-type ribozyme (czS 
reaction), but decreased twofold for the 187-nt trans 
ribozyme using the 5’-Phe 8-mer RNA substrate. We also 
performed tram reactions using 2-8 pM ribozyme with 
30-260 pM 8-mer substrate to quantitate product forma- 
tion. We found that 1 mol of the 187-nt ribozyme can 
produce about 2 mol of Bio-Met-Phe-Smer product. The 
187-nt ribozyme is therefore capable of at least two 
turnovers under these reaction conditions. A maximum 
of lo-20% of the clone 25 RNA is reactive in the cis reac- 
tion; if the tram reaction is equally efficient, then the 
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Figure 6 
The trans substrate structures and the gel 
analysis of the bisubstrate reactions. (a) The 
line-drawing structure illustrates the clone 25 
ribozyme and three new trans substrates: the 
20-mer is shown, the 8-mer is 5’.Phe-linker- 
GGGAGAG and the 4-mer is 5’-Phe-linker- 
GGGA. The three new truncated frans 
ribozymes are 5’-GG-173 nt, 5’-GG-185 nt 
and 5’-GG-191 nt. (b) The autoradiogram of 
the gel analysis of trans reactions catalyzed by 
the 175~nt clone 25 frans ribozyme with the 
5’-Phe-20-mer RNA substrate. The reactions 
were performed with 8 FM trans ribozyme and 
about 20 PM 5’-Phe-20-mer RNA, 800 PM 
AMP-Met-Bio, 300 mM KCI and 50 mM 
HEPES (pH 7.4) at 25%. (c) Autoradiogram 
of the gel analysis of the frans reaction 
catalyzed by the 187-nt clone 25 tram 
ribozyme with the 5’-Phe-8-mer RNA 
substrate. The reactions were performed in 
8 pM frans ribozyme, 66 FM 5’sPhe-8-mer 
RNA, 800 PM AMP-Met-&o, 300 mM KCI and 
50 mM HEPES (pH 7.4) at 25%. 
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actual number of turnovers per active ribozyme is calcu- 
lated to be 10-20. 
Chemical modification by DMS and CMCT was also per- 
formed with trans ribozymes plus the ZO-mer or 8-mer RNA 
substrate with or without AMP or AMP-Met-Bio (data not 
shown). All of these chemical-modification experiments 
gave the same modification patterns as shown in Figure 5, 
again with no indication of substrate footprints. 
Testing the secondary-structure model using site-specific 
mutagenesis 
Site-specific mutants were used to test the double-strand 
helices predicted by the secondary-structure model of the 
clone 25 ribozyme. The availability of the trans reaction 
greatly facilitated the synthesis of these mutants, because 
the substrate-coupling steps are not necessary for a tram 
reaction. Three helix regions (P4, P5 and P8) were mutated 
to change the sequence of a single side of each stem (Mut 
l-6), and compensatory mutations were introduced to 
restore the ability of each helix to form (Figure 7a). The 
reactions catalyzed by the Mut 1 and Mut 2 ribozymes 
showed only twofold slower catalysis than that by the 
wild-type ribozyme (Figure 7b). The catalytic activity of 
the mutant ribozyme with P4 compensatory mutations 
(Mut 1:Mut 2) was restored to almost the level of the wild- 
type ribozyme. Thus, the P4 helix appears.to exist, but it 
is not critical for catalysis. Mutation of helix P5, however, 
showed dramatically decreased (Mut 3) or no (Mut 4) 
activity. Restoration of the stem (Mut 3:Mut 4) restored 
activity to near wild-type levels (Figure 7b). The struc- 
ture but not the sequence of helix PS is therefore required 
for catalysis. Mutations of helix P8 showed an observed 
reaction rate for the Mut 5 ribozyme about 200 times 
slower than that ofthe wild-type ribozyme, whereas the 
Mut 6 ribozyme showed no activity. The double mutant 
(Mut S:Mut 6) recovered activity relative to Mut 6, and 
reacted only two times slower than the wild-type 
ribozyme (Figure 7b). It appears that the existence of PX 
and, to a lesser extent, its sequence are important for full 
546 Chemistry & Biology 1996, Vol 5 No 10 
Figure 7 
Mut 
Mut 5:Mut 6 
Mut 1 :Mut 2 
-4 Mut 5:Mut 6 
- Mut5 I 
0 50 100 150 200 250 
Time (min) 
Chemistry & Bialog) I 
Testing the secondary-structure model of the clone 25 ribozyme. 
(a) The specific regions targeted for mutagenesis. (b) The time 
courses of the activity of the mutant ribozymes; P/(P+S), fraction 
product. The reactions were performed using 8 pM 175~nt trans 
ribozyme, 20 pM 5’-Phe-20smer RNA substrate, 800 t.tM AMP-Met-Bio, 
100 mM MgCI,, 300 mM KCI and 50 mM HEPES (pH 7.4) at 25%. 
activity. These data strongly support the existence of the 
stems P4, P5 and P8 and attest to the importance of the P5 
and PS stems for folding and/or catalysis. 
Structural similarity between the clone 25 ribozyme and 
the peptidyl-transferase region of 23s rRNA 
Provocatively, the in vitro selected clone 25 ribozyme 
contains regions that are structurally similar to portions 
of the peptidyl-transferase region of domain V in 23s 
rRNA (Figure 8a,b). Inspection of the 23 nucleotides 
forming the L3/4 loop predicted from the secondary 
structural analysis of the ribozyme revealed that they 
share 70% nucleotide identity with the central loop of 
23s rRNA and that they are present in the same local 
secondary-structure context. The top region (red) of the 
internal loop of clone 25 ribozyme is homologous to the 
top region (red) of the central loop of domain V of 23s 
rRNA. The bottom region (green) of the L3/4 internal 
loop is similar to the bottom region (green) of the pep- 
tidyl-transferase loop of 23s rRNA. 
The L3/4 internal loop is essential for ribozyme catalysis. 
Figure 9a summarizes deletions and mutations tested. 
Deletion of A26-A28 (Del 26-28) resulted in a ZO-fold 
decrease in activity, whereas deletion of A29-A31 
(Del 29-31) resulted in a 150-fold decrease. Substitution 
of all six nucleotides (Mut 7) resulted in a ZOO-fold drop in 
activity. The peptidyl-transferase reaction was unde- 
tectable in the Mut 8 ribozyme (Figure 9a,b); considering 
the limit of detection of the assay, this mutant has less 
than l/600 of the activity of the clone 25 ribozyme. 
A second region (magenta in Figure 8) of similarity 
between the family II ribozymes and 23s rRNA involves 
six nucleotides in the L5 hairpin loop in the clone 25 
ribozyme; five of these nucleotides are identical to those 
found in the same structural content in E. co/i 23s rRNA 
(A2530-G2535), although only the AG is conserved at 
> 90% throughout large subunit rRNAs. Testing of 
mutants Mut 9 and Mut 10 showed that these 
nucleotides in the family II ribozyme are required for its 
peptidyl-transferase activity (Figure 9a,c). 
From the sum of these results, it seems likely that the 
L3/4 internal loop and L5 hairpin loop of the clone 25 
ribozyme constitute at least part of the peptidyl-trans- 
ferase active site of family II ribozymes. Furthermore, 
they lead to the testable hypothesis that these regions 
perform functions analogous to those performed by the 
corresponding sequences in the peptidyl-transferase 
central loop of 23s rRNA. 
Discussion 
The peptidyl-transferase ribozymes catalyze the transfer 
of an amino acid from AMP-Met-Bio to 5’-Phe-RNA to 
form the peptide bond of the reaction product 5’-Bio- 
Met-Phe-RNA. The catalytic reaction by the trans 
ribozyme described herein resembles even more closely the 
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Figure 8 
(a) The peptidyl-transferase central region of 
domain V of 23s rRNA, numbering according 
to E. co/i 23s rRNA. The upper-case letters 
indicate nucleotides universally or highly 
conserved (> 90%) among all large subunit 
rRNAs. Lower-case letters indicate the less 
conserved nucleotides (< 90%). Arrows 
implicate regions involved in peptidyl- 
transferase activity on the basis of mutation, 
cross-link and footprint data. Conservation 
and functional data as summarized by others 
([34,55]). (b) Partial secondary structure of 
the clone 25 ribozyme and 23s rRNA. 
Sequence identities are highlighted in red, 
green and magenta. 
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peptidyl-transferase reaction of the ribosome (Figure 1). 
The two amino-acid substrates of the tram ribozyme are 
each linked to a nucleotide or oligonucleotide, analogous to 
charged tRNAs. The tram ribozyme, like the ribosome, 
has a very specific structure required for catalysis, as evi- 
denced by the destruction of activity by many site-specific 
mutations and deletions. Furthermore; the ribozyme 
portion of the Pl stem mimics mRNA in that it binds the 
oligonucleotide tram substrate, which mimics an anti- 
codon; it might be possible, therefore, to program dipep- 
tide or even oligopeptide synthesis. Mechanistic studies of 
peptide-bond formation catalyzed by the ribozyme might 
help us understand the mechanism of peptide-bond for- 
mation by the ribosome. 
The tram reaction was calculated to convert 2 mol of 
8-mer substrate to product per mole of ribozyme. A 
maximum of lo-20% of the clone 25 RNA is reactive in 
the cis reaction; if the same efficiency pertains to the tram 
reaction, the actual number of turnovers per active 
ribozyme is calculated to be 10-20. We do not know what 
is limiting the reaction. We assume that a better turnover 
number could be achieved by reengineering the tram 
ribozyme and the 5’-Phe-RNA substrate further. For com- 
parison, Nitta et a/. [30] reported that in vitro-transcribed 
E. coli 23s rRNA promoted peptide-bond formation, with 
1 mol 23s rRNA producing 0.0015 mol peptide bonds. 
The turnover efficiency of our synthetic ribozyme is 1,300 
times higher than this rRNA system. 
The family II ribozymes share short regions of sequence 
identity with nucleotides in the central loop of domain \’ 
of 23s rRNA that are conserved among all organisms. 
Several lines of evidence, including RNA cross-linking, 
chemical footprinting, antibiotic footprinting and muta- 
tional analysis, have supported the hypothesis that this 
portion of 23s rRNA is the peptidyl-transferase center of 
the ribosome (Figure 8a) [31-351. Chemical footprinting 
indicated that a number of nucleotides in domain V are 
located in the binding sites for the donor and acceptor 
tRNA substrates [36]. Cross-linking between benzophe- 
none-derivatized peptidyl-tRNA (BP-Phe-tRNA) and 
A2451-(32452 of the ribosome localized this region to the 
peptidyl-transferase center [37]. The AZ451-C2452 region 
is also likely to be a hydrophobic binding site where the 
sidechains of aromatic amino acids bind. based on suh- 
strate affinity and aromatic antibiotic inhibition experi- 
ments [38,39]. The A2059-G2061 region is also 
hypothesized to be the peptidyl-transfernse site based on 
sequencing of antibiotic resistant mutants and antibiotic 
footprints [40,41]. Site-directed mutagenesis experiments 
suggested a potential A76-172585 Hoogsteen pair between 
the 3’-terminal adenosine base of the peptidyl donor 
tRNA and the 23s rRNA [42]. Cross-linking of RP-Phe- 
tRNA with 23s rRNA also localized Y2584 and 172.585 to 
the ribosomal 4 site and A2503 and 1.72.506 to either the A 
or the P site [37]. Mutational studies revealed that 
nucleotides Y2580-G2.582 form a binding pocket for C75 
of the peptidyl-tRNA [32]. 
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Figure 9 
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Testing the significance of the regions of similarity between clone 25 ribozyme and 23s rRNA. (a) The specific regions of the mutations and 
deletions. (b-c) The autoradiograms of the gel analyses of the activity of the mutant ribozymes. The reaction conditions were as described 
in Figure 7. 
The mutational analysis presented here shows that the 
regions of the clone 25 ribozyme that resemble 23s rRNA 
are functionally important for peptidyl transfer. By analogy 
to 23s rRNA, these sequences might be involved in 
binding AMP-Met-Bio and/or the 5’-Phe-linker-RNA sub- 
strates. It is unclear whether the region (A2530-G2535) of 
23s rRNA binds tRNA directly, but the similar region (L.5 
hairpin loop) of the clone 25 ribozyme is necessary for catal- 
ysis of peptide-bond formation. For now, our mutational 
data are consistent with, but do not prove, the proposal that 
these regions of the ribozyme perform similar functions to 
the peptidyl-transferase central region of 23s rRNA. Future 
cross-linking experiments will be needed to test this 
hypothesis and search for the exact substrate-binding sites. 
Interestingly, the family II ribozyme (clone 25) also shows 
homology to two RNA aptamer families that were selected 
for their ability to bind to CCdApPuro, a ribosomal pep- 
tidyl-transferase inhibitor [43]. The CCdApPuro-binding 
aptamers contain a consecutive eight-base binding motif 
matching the peptidyl-transferase loop (A2448-G245.5) of 
23s rRNA. The clone 25 ribozyme contains a similar 
region at nucleotides 2631, providing further evidence 
that the large internal loop of the clone 25 ribozyme might 
form part of the substrate-binding sites. 
Remarkably, natural selection and in aitro selection have 
yielded similar RNA structures that catalyze peptidyl 
transfer. The notion of ‘molecular determinism’ might 
therefore be applicable to this convergence [44]. Neverthe- 
less, the finding of ribozyme peptidyl transferases does 
provide evidence for the feasibility of the RNA world 
hypothesis by verifying that a key assumption - protein- 
free RNA-mediated peptide-bond formation - is more 
than theoretically possible. A specific physical example can 
now be cited and subjected to further study. 
We demonstrated that the AMP moiety is the major 
binding group of the AMP-Met-Bio substrate. Many 
small molecules including nucleotides, amino acids, dyes 
and organic compounds bind strongly and specifically to 
ribozymes and RNA aptamers. For example, the Tetrahy- 
mena ribozyme has a guanosine-binding site with a K, of 
500 FM [45,46]. Similarly, small ATP-binding RNA 
aptamers bind ATP with a K, of about 10 yM [47]. The 
binding constant of arginine with another RNA aptamer 
is about 330 nM [48]. The binding of the AMP-Met-Bio 
substrate to the clone 25 ribozyme is not overwhelmingly 
strong (K, = 190 PM), but it must be kept in mind that 
we selected for the best active ribozyme, not for the 
strongest-binding aptamer. 
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Figure 10 
Synthesis of AMP-amino acid-Bio substrates 
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4a-d. (a) N-Hydroxyl-succinimide, DCC, 
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Chemistry & Biology 
The difference in metal-ion dependence could reflect a 
difference in the structural folding of the two ribozyme 
families. In general, divalent metal ions might be required 
for structural stabilization of RNA, as well as catalytic 
activity [49-511. Thus, the lower requirement for Mgz+ by 
family I ribozymes could reflect a more stable RNA struc- 
ture. The ability of both families of ribozyme to function 
in Ca2+ is not unprecedented. It is known that the Tetrahy- 
mena ribozyme folds well in either Mgz+, Mn*+ or Ca2+, 
although Ca2+ by itself does not support activity [%?I. In 
the case of the hammerhead ribozyme, Ca2+ can replace 
Mg*+ for activity [53]. Ribosome-catalyzed peptidyl trans- 
ferase can also use Caz+ in place of Mg*+ [54]. 
Significance 
The order of appearance of DNA, RNA and proteins 
during early biological evolution has important implica- 
tions for the origin of life. The ‘RNA world’ hypothesis, 
which holds that RNA was a precursor to extant life, 
requires that RNA be able to direct protein synthesis in 
addition to catalyzing RNA replication. In vitro selec- 
tion methods were used previously to isolate ribozymes 
that can catalyze the transfer of a peptidyl residue from 
a 2’(3’)-aminoacyl-AMP substrate to an amino acid 
linked to the S-end of an RNA. Two major families 
from the final selection pool showed similar catalytic 
rates but different primary sequences and different metal 
ion requirements. One of these ribozymes has now been 
re-engineered to catalyze intermolecular peptide-bond 
formation using an aminoacylated nucleotide and an 
amino-acid-linked oligonucleotide as substrates. Our 
results demonstrate that a ribozyme can catalyze 
peptide-bond formation reactions analogous to the action 
of the ribosome and, most surprisingly, appears to use 
similar sequence and structure motifs. These findings 
provide evidence for the feasibility of the ‘RNA world’ 
hypothesis by demonstrating that RNA itself can make 
peptides, and also support the idea that ribosomal RNA 
has a catalytic function in the modern-day ribosome. 
Furthermore, the study of peptidyl transfer by the 
ribozymes could shed light on the mechanism of riboso- 
ma1 peptidyl transfer. 
Materials and methods 
General and materials 
l H-NMR spectra were recorded on a Varian VXR 300 MHz or a Bruker 
AM-400 MHz spectrometer. All spectra used the residual solvent peaks 
as reference signals. Mass spectra were recorded on a Jeol JMS-DX- 
303 HF instrument (for FAB spectra) or a Hewlett-Packard 5989B 
HPLC-MS (for electrospray ionization mass spectra). Oligonucleotides 
were synthesized on an Applied Biosystems oligonucleotide synthesizer 
Model 394 using standard phosphoramidite chemistry. Chemicals, sol- 
vents, drying agents and inorganic salts were obtained from Fisher Sci- 
entific Co., Sigma Chemical Co., Fluka Chemical Co. or Aldrich 
Chemical Co. unless otherwise indicated. DMS was purchased from 
Aldrich and CMCT from Sigma. Anhydrous N,N-dimethyl formamide, 
tetrahydrofuran and methyl sulfoxide were obtained in Sure/SealTM 
bottles from Aldrich Chemical Co. Guanosine-5’-monophosphorothioate 
(GMPS), dNTPs, NTPs, restriction enzymes and AMV reverse transcrip- 
tase were purchased from Amersham, immobilized streptavidin and 
streptavidin from Pierce, glycogen and Taq DNA polymerase from 
Boehringer Mannheim, RNase-free DNase I from Promega, w~~P-ATP 
and rssS-ATP from DuPont NEN. T7 RNA polymerase was supplied by 
A. Gooding. Aqueous buffers were prepared with autoclaved deionized 
water and pH values were adjusted with 1 N HCI or 1 N NaOH. 
Chemical synthesis 
The syntheses of aminoacyl esters 4a-d are shown in Figure 10. The 
biotinylamidocaproic acid was coupled with N-hydroxysuccinimide cat- 
alyzed by DCC and then reacted with L-amino acids or NWBOC-lysine 
to give N-biotinylamidocaproyl-L-aminoacyl (3a-d) in 90% yield. The 
compounds 3a-d were converted to imidazole intermediates by treat- 
ing with carbonyldiimidazole in DMF and esterified with adenosine-5’. 
monophosphate (and deprotected using trifluoroacetic acid for the 
lysine compound) to produce the desired aminoacyl ester products 
4a-d in 30-65% yield. 
Our method for synthesis of the phenylalanine linker is outlined in 
Figure 11. N-t-BOC-phenylalanine-N-hydroxysuccinimide ester (5) was 
coupled with cystamine dihydrochloride salt (6) in triethylamin- 
methanol-DMF mixed solvent to give monomer 7, which was reacted 
with bromoacetyl-N-hydroxysuccinimide ester and deprotected by triflu- 
oroacetic acid to afford the final desired N-bromoacetyl-N’-phenyl- 
alaninylcystamine (9) in 72% yield. 
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Fiaure 11 
Synthesis of the phenylalanine linker and its 
conjugation to the RNA. (a) TEA/MeOH/DMF, 
24 h, rt, 58%; (b) Bromoacetyl-N-hydroxyl- 
succinimide ester, DMF, 10 h, rt; 
(c) Trifluroacetic acid, methylene chloride, 2 h, 
0-5’C, 71.9%; (d) 5’-GMPS-RNA, 10 mM 
HEPES buffer, pH 7.7, overnight, 4’C. 
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Biotinylamidocaproyl-N-hydroqsuccinimide ester 2. Biotinyl-6-amino- 
caproic acid (1 .O g, 2.8 mmol), N-hydroxysuccinimide (0.33 g, 2.9 mmol) 
and DMAP (0.04 g, 0.31 mmol) were dissolved in 20 ml of DMSO and 
20 ml of DMF. A solution of 0.64 g (3.08 mmol) of DCC in 10 ml of DMF 
was added to the above mixture with stirring at room temperature. The 
reaction solution was stirred for 24 h at room temperature, filtered and 
evaporated by vacuum to afford the product as a white solid that was 
purified by recrystallization from acetone (85.8%). ‘H-NMR (300 MHz, 
DMSO-d,): 6 1.25-l .60 (m, 1 OH), 2.05 (t, 2H), 2.55 (d, 1 H), 2.62 (t, 2H), 
2.80 (m, 3H), 2.95 (q, 2H), 3.10 (m, 1 H), 3.35 (s, 4H), 4.13 (m, 1 H), 
4.32 (m, 1 H), 6.38 (s, NH, 1 H), 6.45 (s, NH, 1 H), and 7.75 (t, 1 H). 
N-Biotinylamidocaproyk-amino acid 3a-d. Triethylamine (1 ml) was 
added dropwise to a stirred solution of biotinylamidocaproyl-N- 
hydroxysuccinimide ester (2); (0.5 g, 1.1 mmol) and L-amino acid 
(0.25 g, 1.65 mmol) in 50 ml of DMF. The mixture was stirred for 48 h 
at room temperature. After removing the white precipitate by filtration, 
the filtrate was evaporated under reduced pressure. The organic solid 
was dissolved in a minimal amount of DMF and precipitated with 
acetone. The white solid product was collected and re-precipitated 
three times to give a pure product (90%). 
N-Biotinyamidocaproyl-r-methionine 3a. ‘H-NMR (300 MHz, DMSO-d,): 
61.20-1.62 (m, 16H), 1.80-2.00 (m, 2H), 2.05 (s, CH,, 3H), 2.12 (t, 2H), 
2.55 (d, 1 H), 2.85 (dd, 1 H), 2.95 (q, 2H), 3.10 (m, 1 H), 4.12 (m, 1 H), 
4.30 (m, 2H), 6.38 (s, NH, 1 H), 6.45 (s, 1 H), 7.75 (t, NH, 1 H), and 8.12 
(d, NH, 1 H); mass spectrum (ESI), m/e = 489(M+l). 
N-BiotinylamidocaproykL-leucine 3b. ‘H-NMR (300 MHz, DMSO-d,): 
60.82 (d, 3H, C(CH,),), 0.89 (d, 3H, C(CH,),), 1.18-1.60 (m, 15H), 
2.12 (m, 4H), 2.55 (d, lH), 2.80 (dd, lH), 2.95 (q, 2H), 3.10 (m, lH), 
4.12 (m, 2H), 4.30 (m, lH), 6.36 (s, NH, lH), 6.45 (s, lH), 7.75 (t, NH, 
1 H), and 6.02 (d, NH, 1 H). 
N-Biotinylamidocaproyl-L-phenylalanine 3c. ’ H-NMR (300 MHz, 
DMSO-d,): 61.12-1.62 (m, 14H), 2.05 (bs, 4H), 2.55 (dd, 1 H), 2.85 
(m, 1 H), 2.95 (m, 2H), 3.10 (m, 1 H), 4.12 (m, 1 H), 4.25 (m, 1 H), 4.40 
(m, lH), 6.38 (s, NH, lH), 6.45 (s, lH), 7.24 (m, 5H), 7.75 (t, NH, lH), 
and 8.12 (d, NH, 1 H). 
N-Biotinylamidocaproyl-NE-t-Boc-L-&sine 3d. ‘H-NMR (300 MHz, 
DMSO-d,J: 61.20-l .65 (m, 25H), 2.00-2.12 (m, 4H), 2.55 (m, 2H), 
2.85 (m, 2H), 2.95 (m, 2H), 3.10 (m, 2H), 4.12 (m, 2H), 4.30 (m, lH), 
6.38 (s, NH, lH), 6.45 (s, lH), 6.78 (s, lH), 7.75 (s, NH, lH), and 
6.12 (d, NH, 1 H). 
3’(2 ~-N-Biotinylamidocaproyl-L-aminoacyl-adenosine-5’-monophosphate 
4a-d. N-biotinylamidocaproyl-L-amino acid (0.55 g, 1 .l mmol) (3a-d) 
and 1 ,l’-carbonyldiimidazole (0.27 g, 1.65 mmol) in 5 ml of anhydrous 
DMF were stirred for 15 min at room temperature. The solution was 
added into a stirred solution of adenosine-5’-monophosphate 
monosodium (1.2 g, 3.3 mmol) in 10 ml of formamide at room tempera- 
ture. The mixture was stirred overnight at room temperature and then 
precipitated with 200 ml of a 1:l (v:v) mixture of acetone and ethyl 
ether. After centrifugation and washing with 100 ml of ethyl ether, the 
crude product was purified by silica gel chromatography eluted with 
n-butanol:acetic acid:water = 78:5:17 (v/v). The desired product was 
collected to give 600/o yield (70% 3’-isomer and 30% 2’-isomer). 
3’(2~-N-Biotinylamidocaproy/-~-methionyl-adenosine-5’-monophosphate 
4a. Rr = 0.55 (n-BuOH:AcOH:H,O = 5:2:3). ‘H-NMR (400 MHz, D,O): 
61.22-1.70 (m, alkyl protons), 2.12 (s, CH,, 3H), 2.15 (m, 2H), 2.32 (m, 
lH),2.70(d, lH),2.90(d, lH),3.12(m,2H),3.2(m, lH),4.12(m,2H), 
4.15 (m, 1 H), 4.32 (m, 2H), 4.95 (m, 2’-H, 3’-isomer), 5.55 (m, 3’-H, 3’- 
isomer), 5.58 (m, 2’-H, P’-isomer), 6.12 (d, l’-H, 3’-isomer), 6.32 (d, l’- 
H, 2’-isomer), 8.23 (s, P’-isomer), 8.25 (s, 3’-isomer), 8.45 (s, P’-isomer), 
and 8.50 (s, 3’-isomer); mass spectrum (ESI), m/e = 818 (M+l). 
3’(23-N-Biotinylamidocaproyi-~-leucinyl-adenosine-5’monophosphate 
46. Rr = 0.54 (n-BuOH:AcOH:H,O = 5:2:3). l H-NMR (300 MHz, D,O): 
60.46-0.62 (dd, 2’sisomer, C(CH,),), 0.65-0.80 (dd, 3’-isomer, C(CH,),), 
1 .12-l .56 (m, alkyl protons), 1.96 (m, 3H), 2.16 (t, 1 H), 2.50 (t, 1 H), 2.70 
(dd, 1 H), 2.90 (t, 2H), 3.02 (m, 1 H), 3.85 (m, 2H), 4.22 (m, 2H), 4.30 (m, 
lH), 4.35 (m, 2H), 4.95 (m, 2’-H, 3’-isomer), 5.35 (q, 3’-H, 3’-isomer), 
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5.39 (m, 2’.H, P/-isomer), 5.92 (d, l’-H, 3’-isomer), 6.08 (d, 1’.H, 
P/-isomer), 8.03 (s, 9’.isomer), 8.25 (s, P’-isomer), 8.39 (s, 2’-isomer), 
and 8.40 (s, 3’-isomer); mass spectrum (ESI), m/e=800 (M+l). 
3’(23-N-Biotiny/amidocaproy/-~-pheny/a/any/-adenos;ne-5’-mono~~os- 
ohate 4c. R, = 0.53 (n-BuOH:AcOH:H,O = 5:2:3). ‘H-NMR (300 MHz, 
D,O): 60.90-l .50 (m, alkyl protons), 2.00-2.12 (m, 5H), 2.60-2.90 (m, 
6H), 3.20 (m, 1 H), 3.80 (m, 3H), 4.02-4.20 (m, 3H), 4.32 (m, 2H), 4.95 
(m, 2’sH, 3’-isomer), 5.55 (m, 3-H, 3’.isomer), 5.58 (m, 2,-H, 
2’.isomer), 6.12 (d, l’-H, 3’-isomer), 6.32 (d, l’-H, 2’-isomer), 6.80 (m, 
P’-isomer), 7.10 (m, 3’-isomer), 8.00 (dd, 1 H), 8.35 (s, 2’.isomer), and 
8.40 (s, 3’.isomer); mass spectrum (ESI), m/e = 834 (M+l). 
3’(2~-N-Biotinylamidocaproyl-~-lysinyl-adenos~ne-5’-monophosphate 4d. 
R,= 0.48 (n-BuOH:AcOH:H,O = 5:2:3). ‘H-NMR (300 MHz, D,O): 
81.22-l 70 (m, alkyl protons), 2.08 (m, 2H), 2.20 (m, 1 H), 2.60 (d, 1 H), 
2.80 (m, 2H), 2.95 (m, lH), 3.12 (m, 1 H), 3.95 (m, 2H), 4.22 (m, lH), 
4.38 (m, 2H), 4.85 (m, 2’-H, 3’-isomer), 5.40 (m, 3’.H, 3’-isomer), 5.50 
(m, 2’-H, 2’.isomer), 6.08 (d, I’-H, 3’-isomer), 6.20 (d, l’-H, 2’-isomer), 
8.30 (s, 3’.isomer), 8.48 (s, 2’-isomer), 8.50 (s, 2’-isomer), and 8.52 (s, 
3’.isomer); mass spectrum (ESI), m/e = 815 (M+l). 
N-t-BOC-L-Phenylalanyl-cystamine 7. To a solution of cystamine (6.8 g, 
30 mmol) and 20 ml of triethylamine in 100 ml of methanol was added 
a solution of t-BOC-L-phenylalanyl-N-hydroxysuccinimide ester (3.62 g, 
10 mmol) in 40 ml of DMF at room temperature. The mixture was 
stirred overnight at room temperature. After removing the solvent by 
distillation under reduced pressure, the residue was dissolved in ethyl 
acetate and washed with saturated sodium bicarbonate once and with 
water twice. The organic layer was dried with anhydrous sodium sulfate 
and evaporated by rotavapor. The crude product was purified by flash 
chromatography with silica gel (eluted with 10% methanol in methylene 
chloride) to give the pure desired product (58%). ‘H-NMR (300 MHz, 
CDCI,): F 1.25 (s, 9H), 2.65-2.79 (m, 4H), 2.92 (dd, 2H), 3.23-3.41 
(m, 2H), 4.15 (m, 1 H), 6.92 (d, NH, 1 H), 7.25 (m, aromatic, 5H) and 
8.15 (t, NH, 1 H); mass spectrum (ESI), m/e = 400 (M+l). 
Bromoacetyl-N-hydroxysuccinimide ester. A solution of DCC (11.35 g, 
55 mmol) in 30 ml of anhydrous THF was added to a solution of N- 
hydroxysuccinimide (5.75 g, 50 mmol), bromoacetic acid (6.94 g, 
50 mmol) and DMAP (0.61 g, 5 mmol) in 80 ml of anhydrous THF at 
0°C (ice-bath). The mixture was stirred overnight at room temperature. 
After filtering out the precipitate, the filtrate was evaporated under 
reduced pressure to dryness. The crude product was purified by 
recrystallization from hot ethyl acetate (92%). ‘H-NMR (300 MHz, 
CDCI,): 6 2.82 (s, 4H) and 4.05 (s, BrCH,, 2H). 
N-L-Phenylalanyl-N’-bromoacefyl-cystamine 9. A solution of N-t-BOC- 
L-phenylalanylcystamine (7) (1 g, 2.5 mmol) and bromoacetyl N-hydrox- 
ysuccinimide ester (1 g, 4.2 mmol) in 30 ml of anhydrous DMF was 
stirred for 10 h at room temperature. After removing the solvent by 
evaporation under reduced pressure, the residue was dissolved in 
chloroform and any insoluble material was removed by filtration. The 
clear solution was loaded on a silica gel column and first eluted with 
chloroform and then eluted with 10% methanol in chloroform to collect 
the pure desired product. The product 8 was dissolved in 20 ml of 
methylene chloride and deprotected with 2 ml of trifluoroacetic acid at 
O-5% (ice-water bath). The mixture was stirred for 2 h at O-5’%, and 
then warmed up to room temperature for 10 min. After evaporating the 
solvent under reduced pressure, the solid compound was triturated 
three times with ethyl ether to give the pure product 9 (71.9%). ‘H-NMR 
(300 MHz, DMSO-d,): 6 2.51-2.78 (m, 6H), 2.98 (m, 2H), 3.35 (m, 2H), 
3.85 (s, 2H), 3.95 (t, lH), 7.20-7.35 (m, 5H), 8.20 (wide, NH,, 2H), 
8.50 (t, 1 H) and 8.59 (t, 1 H); mass spectrum (ESI), two equal intensity 
mass peaks: m/e = 420 (M+l) [35Br] and 422(M+3) [s7Br]. 
Ribozyme synthesis 
All trans ribozymes were prepared by runoff transcription with T7 RNA 
polymerase using the products of PCR amplification of the corresponding 
cDNAs as templates, Transcription reactions were carried out in the 
presence of 12 mM Mg*+, 2 mM each GTP, ATP, CTP and UTP, and 
10 ug of DNA template in a total 200 ul solution. For cis reactions, the 
ribozymes were synthesized by runoff transcription in the presence of 
guanosine-5’.monophosphorothioate (GMPS) wrth a ratio of 
GMPS:GTP:ATP:CTP:UTP = 8:0.4:1 :l :l mM and [~x-~~P]-ATP. The 
body-labeled 5’-GMPS-ribozymes were purified by denaturing 7.5 M 
urea/8% polyacrylamide gel electrophoresis and reacted with Phe- 
linker-CH,Br in 10 mM HEPES (pH 7.7) and 1 mM EDTA at 4°C 
overnight. The 5’.Phe-linker-ribozymes were similarly purified by dena- 
turing polyacrylamide gel electrophoresis, resuspended in pure water 
and stored in -7O”Cfreezer. 
5’-Phe-linker-RNA substrate preparation 
5’.Phe-linker-GGGAGAGA-3’, 5’.Phe-linker-GGGAGAGACCUGCCA- 
UUCA-3’ and 5’.Phe-linker-GGGA-3’. RNA substrates were pre- 
pared in the same manner as the 5’-Phe-linker-ribozymes described 
above. Alternatively, RNA oligonucleotides were synthesized on an auto- 
mated synthesizer and reacted with [y-s5S]-ATP catalyzed by T4 polynu- 
cleotide kinase. The 5’-[35S]-GMPS-RNAs were purified by denaturing 
20% polyacrylamide gel electrophoresrs and then treated with Phe- 
linker-CH,Br to afford the 5’-Phe-linker-RNA used for the trans reactions. 
Kinetic assays 
All single turnover cis reactions were carned out with uniformly [r~?~Pl- 
ATP-labeled ribozyme and excess AMP-Met-Bio substrate (2 1 OO-fold) 
in 50 mM HEPES (pH 7.4), 300 mM KCI and 50 mM MgCI, at 25°C. 
The RNA was preincubated with buffer and Mg*+ for 10 min at 50°C 
and cooled to room temperature (-20 min). The reaction was initiated 
by addition of AMP-Met-Bio substrate. Aliquots of 2 ul were removed 
from 20 1.11 reaction mixtures at specific time points, quenched with an 
equal volume of stop buffer containing 100 mM HEPES (pH 7.4) and 
100 mM EDTA and frozen on dry ice. Thawed samples were incubated 
with 10 ug of streptavidin in the binding buffer (20 mM HEPES, pH 7.4, 
5.0 mM EDTA and 1 .O M NaCI) at room temperature for 20 min prior to 
mixing with 0.25 volumes of formamide loading buffer (90% formamide, 
0.01 ‘J/o bromophenol blue and 0.025% xylene cyanol). The biotinylated 
RNA products were resolved by electrophoresis on 7.5 M urea/8% 
polyacrylamide gels. The fraction of product formation relative to total 
substrate and product at each time point was quantitated using a Mol- 
ecular Dynamics Phosphorlmager. 
Trans reaction assays 
The trans reactrons were performed in a similar fashion as described 
above, except that ribozymes were preincubated with 5’-Phe-linker- 
RNA substrate and streptavidin was not added because it was not 
needed to resolve the reaction products from the unreacted RNAs. The 
ribozyme was preincubated in the presence of Mg*+ with at least a 1 O- 
fold greater concentration of 5’-Phe-linker-RNA substrate for 10 min at 
50°C then cooled slowly to room temperature for about 20 min. Then 
2 ul of 8 mM AMP-Met-Bio (10 x) solution was added to initiate the 
reaction at 25°C. A 2 ul sample was removed from the 20 1.11 reaction 
mixture at each specific time point, quenched with an equal volume of 
formamide loading buffer (90% formamide, 0.01% bromophenol blue 
and 0.025% xylene cyanol) and by immediately freezing on dry ice. The 
samples were loaded on a denaturing 20% polyacrylamide gel. The 
rest of the analysis was as described above. 
Chemical modification 
A total of 30 ul of 193.nt clone 25 RNA (24 pmol) or 175~nt clone 25 
RNA (30 pmol) with 20 nt RNA substrate (30 pmol) solution was 
annealed in the reaction buffer (10 x DMS buffer: 500 mM HEPES, 
pH 7.4; 3.0 M KCI; 10 x CMCT buffer: 500 mM NaB(OH),, pH 8.0; 
3.0 M KCI) by boiling for 90 s at 90°C, and air-cooling to room temper- 
ature for about 10 min. Then 3 ul of 1 .O M MgCI, and/(when indicated) 
3 ul of 8 mM AMP-Met-Bio (or 40 mM AMP and 1 mM Phe-linker- 
CH,Br or 30 uM 5’-Phe-linker-RNA) was/were added. The mixture was 
incubated for IO mm at 50X, cooled to room temperature for 20 min. 
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Fresh DMS stock solution (3 1.11, 1:lO = DMS:ethanol) or fresh CMCT 
stock solution (5 ~1, 42 mg/l CMCT in water) was added and incubated 
for 20 min (DMS) or 30 min (CMCT) at 25’C. The reaction was 
stopped by addition of 15 ~1 of stop solution (1.5 M NaOAc [pH 5.51, 
1 .O mM EDTA and 0.1 pg/pl linear acrylamide) and precipitated with 
450 pl of cold ethanol (20-30 min on dry ice and centrifuged for 1 O- 
15 min). The pellet was resuspended in 20 ~1 of water. 
Reverse transcription 
Primer 1: 5’-CACGGATCCTGACGCTGCTT-3’, corresponding to 
residues 193-l 74 of clone 25 ribozyme; primer 2: 5’~CCGGGGATG- 
TAAGGTCGCTGC-3’, corresponding to residues 112-93 of clone 25 
ribozyme. 1 pl of 5’ labeled primer (2 x 10s cpm/@) was annealed with 
1 ~1 of chemically modified ribozyme (1.2 pmol/yl) or control RNA in 
6 pl of AB buffer (40 mM TrisHCI, pH 8.3; 4.8 mM NaCI; 8 mM Dll) by 
boiling for 90 seconds at 90°C and cooling to room temperature. 
Reverse transcription was performed by adding 6 PI of RT-dNTP mix 
(40 mM TrisHCI, pH 8.3; 3 units AMV reverse transcriptase; 6 mM 
Mg(OAc),; 0.5 mM dNTP) and incubating for 30 min at 25’C. The 
reaction was stopped by addition of 12 ~1 of formamide stop buffer and 
boiled for 3 min before being loaded on a denaturing 20% polyacry 
lamide gel and analyzed as described above. 
Enzymatic probing 
The enzymatic digestion reactions were performed in 16 mM sodium 
citrate buffer (pH 5.5) for RNase U2 and 20 mM Tris-HCI buffer 
(pH 7.5) for RNase Tl, T2, Vl, and Nuclease Sl in the presence of 
100 mM KCI and 20 mM MgCI, for 20 min at 3O’C. A total of 6 yl of 5 
labeled RNA (2.0 x 1 O6 CPM) solution was incubated with 2 pl of the 
appropriate diluted RNase solution: 5.0 x 10-s U/p1 of RNase Tl, 
5.0 x 1 O-3 U@l of RNase T2, 1002 lJ/~l of Nuclease Sl , 3.6 x 1 O-5 U/p1 
of RNase Vl or 1 .O U&l of RNase U2. The reactions were stopped by 
adding an equal volume of stop buffer solution (9 M urea, 10% [v/v] 
glycerol, 0.05% [w/v] XC and 0.05% [w/v] BPB) and by immediately 
freezing on dry ice. The hydroxide ladder reaction was carried out with 
2 ~1 of 5’ labeled RNA in 4 PI of hydroxide hydrolysis buffer (50 mM 
NaHCO,/Na,CO,, pH 9.2 and 1 mM EDTA) for 5-7 min at QO’C and 
then immediately plunged into an ice-slurry bath. The control reaction 
was performed with 2 pl of 5’ labeled RNA in RS buffer (20 mM sodium 
citrate, pH 5.0, 1 mM EDTA and 7 M urea) for 3 min at 5O’C and imme- 
diately plunged into an ice-slurry bath. The samples were loaded on a 
20% polyacrylamide/7 M urea gel and analyzed as described above. 
Mutant ribozymes 
Site-specific mutations in the ribozymes were made by first introducing 
the mutations into the corresponding cDNA templates by PCR amplifi- 
cation using the appropriate primers containing the desired base 
changes. The PCR was carried out with 0.5~~ of clone 25 plasmid 
DNA, 2 pM primers, 0.4 mM each dNTP and 5 U Taq DNA polymerase 
in the presence of 3.0 mM MgCI, for 25 thermal cycles (94’C for 3% 
55% for 30s and 72’C for 60s). The products of the PCR mutagene- 
sis were used as templates for runoff transcription reactions, as 
described above, to generate the desired mutant ribozymes. Ribozyme 
activity was analyzed as described above. 
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